NCT02765802View on ClinicalTrials.gov

A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 19, 2016

Primary Completion Date

July 20, 2018

Study Completion Date

December 12, 2018

Conditions
Hepatitis D, Chronic
Interventions
DRUG

Peginterferon Lambda-1A

Trial Locations (4)

1142

Auckland City Hospital, Grafton

74800

The Aga Khan University and Hospital, Karachi

84101

Soroka Medical Center, Beersheba

9103102

Shaare Zedek Medical Center, Jerusalem

Sponsors
All Listed Sponsors
lead

Eiger BioPharmaceuticals

INDUSTRY

NCT02765802 - A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection | Biotech Hunter | Biotech Hunter